Your shopping cart is currently empty

POT-4 acetate inhibits Complement C3 activation. POT-4 acetate can be used for studies about age-related macular degeneration.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $187 | Inquiry | Inquiry | |
| 5 mg | $383 | Inquiry | Inquiry | |
| 10 mg | $597 | Inquiry | Inquiry | |
| 25 mg | $1,217 | Inquiry | Inquiry | |
| 50 mg | $1,895 | Inquiry | Inquiry | |
| 100 mg | $2,747 | Inquiry | Inquiry |
| Description | POT-4 acetate inhibits Complement C3 activation. POT-4 acetate can be used for studies about age-related macular degeneration. |
| In vitro | POT-4 acetate, a compstatin derivative, binds to C3 and prevents cleavage to its active fragments C3a and C3b[1]. |
| Synonyms | POT-4 acetate (934461-40-2 free base) |
| Molecular Weight | 1687.9 |
| Formula | C74H106N22O20S2 |
| Smiles | O=C(N[C@H](C(N[C@@](C(N[C@H](C(NCC(N[C@H](C(N[C@H]1CC2=CN=CN2)=O)C)=O)=O)CC3=CNC4=CC=CC=C34)=O)([H])CC(O)=O)=O)CCC(N)=O)[C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC1=O)([H])CCCNC(N)=N)=O)C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@@H](NC(C)=O)[C@@H](C)CC)=O)=O)C(C)C)=O)CC5=CN(C)C6=CC=CC=C56.CC(O)=O |
| Sequence | Ile-Cys(1)-Val-Trp(Me)-Gln-Asp-Trp-Gly-Ala-His-Arg-Cys(1)-Thr |
| Sequence Short | ICVXQDWGAHRCT |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.